VulnerabilityModified
CVE-2017-17678
BMC Remedy Mid Tier 9.1SP3 is affected by cross-site scripting (XSS).
MEDIUM 6.1EPSS 0.59%
Does this matter?
Lower severity and a low EPSS score (0.59%). Track it; it rarely justifies an emergency change on its own.
Description
BMC Remedy Mid Tier 9.1SP3 is affected by cross-site scripting (XSS). A DOM-based cross-site scripting vulnerability was discovered in a legacy utility.
- CVSS 3.1
- 6.1 MEDIUMCVSS:3.1/AV:N/AC:L/PR:N/UI:R/S:C/C:L/I:L/A:N
- EPSS
- 0.59% probability · 48th percentile
- Public exploits
- None in Exploit-DB
- CISA KEV
- Not listed
- Weakness
- CWE-79
- Affected
- bmc/remedy mid-tier
- Source
- cve@mitre.org
EPSS 0.6% since 27 October 2026; no change recorded yet. Points are recorded when the score first appears and whenever it moves by a percentage point or more.
References
- https://docs.bmc.com/docs/ars91/en/9-1-00-fixes-available-for-remedy-ar-system-security-vulnerabilities-800555806.htmlRelease Notes, Vendor Advisory
- https://seclists.org/fulldisclosure/2017/Oct/52Mailing List, Third Party Advisory
- https://docs.bmc.com/docs/ars91/en/9-1-00-fixes-available-for-remedy-ar-system-security-vulnerabilities-800555806.htmlRelease Notes, Vendor Advisory
- https://seclists.org/fulldisclosure/2017/Oct/52Mailing List, Third Party Advisory
Source: NVD record, EPSS from FIRST.org, KEV from CISA, exploits from Exploit-DB. Refreshed daily. Download this record as JSON.